NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma

SIMPLE SUMMARY: This study investigated the relationship between erlotinib resistance and stemness in lung adenocarcinoma. NCAPG2 was identified as an erlotinib resistance gene and maintained the stemness of lung adenocarcinoma. ABSTRACT: Erlotinib is a highly specific and reversible epidermal growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shiyao, Huang, Jingjing, He, Hua, Liu, Yueying, Liang, Lu, Sun, Xiaoyan, Li, Yi, Cong, Li, Qing, Bei, Jiang, Yiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497119/
https://www.ncbi.nlm.nih.gov/pubmed/36139554
http://dx.doi.org/10.3390/cancers14184395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497119/
https://www.ncbi.nlm.nih.gov/pubmed/36139554
http://dx.doi.org/10.3390/cancers14184395

Ejemplares similares